Targeting androgen receptor in BQ323636.1 overexpressing oestrogen receptor-positive breast cancer to overcome aromatase inhibitor resistance: abridged secondary publication

Hong Kong Med J. 2023 Feb;29 Suppl 1(1):12-13.

Authors

H Tsoi¹, E P S Man¹, J Lok¹, C N Cheng¹, L S Wong², S Y Chan², M H Leung¹, W L Chan³, U S Khoo¹

Affiliations

¹ Department of Pathology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
² Department of Clinical Oncology, Queen Mary Hospital, Hong Kong SAR, China.
³ Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

PMID: 36919211

No abstract available

MeSH terms

Aromatase Inhibitors / pharmacology
Aromatase Inhibitors / therapeutic use
Breast Neoplasms* / drug therapy
Breast Neoplasms* / genetics
Drug Resistance, Neoplasm / genetics
Female
Humans
Receptors, Androgen / genetics
Receptors, Estrogen / genetics

Substances

Aromatase Inhibitors
Receptors, Estrogen
Receptors, Androgen